These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

567 related articles for article (PubMed ID: 31865729)

  • 1. MicroRNA-155 promotes the ox-LDL-induced activation of NLRP3 inflammasomes via the ERK1/2 pathway in THP-1 macrophages and aggravates atherosclerosis in ApoE-/- mice.
    Yin R; Zhu X; Wang J; Yang S; Ma A; Xiao Q; Song J; Pan X
    Ann Palliat Med; 2019 Nov; 8(5):676-689. PubMed ID: 31865729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-181a regulates the activation of the NLRP3 inflammatory pathway by targeting MEK1 in THP-1 macrophages stimulated by ox-LDL.
    Song J; Yang S; Yin R; Xiao Q; Ma A; Pan X
    J Cell Biochem; 2019 Aug; 120(8):13640-13650. PubMed ID: 30938884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin reduced NLRP3 inflammasome activity in Ox-LDL stimulated macrophages through adenosine monophosphate activated protein kinase and protein phosphatase 2A.
    Zhang L; Lu L; Zhong X; Yue Y; Hong Y; Li Y; Li Y
    Eur J Pharmacol; 2019 Jun; 852():99-106. PubMed ID: 30851273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-9 Inhibits NLRP3 Inflammasome Activation in Human Atherosclerosis Inflammation Cell Models through the JAK1/STAT Signaling Pathway.
    Wang Y; Han Z; Fan Y; Zhang J; Chen K; Gao L; Zeng H; Cao J; Wang C
    Cell Physiol Biochem; 2017; 41(4):1555-1571. PubMed ID: 28334721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-223-3p inhibits oxidized low-density lipoprotein-mediated NLRP3 inflammasome activation via directly targeting NLRP3 and FOXO3.
    Xu W; Qian L; Yuan X; Lu Y
    Clin Hemorheol Microcirc; 2022; 81(3):241-253. PubMed ID: 35275525
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C1q/TNF-related protein-9 attenuates atherosclerosis through AMPK-NLRP3 inflammasome singling pathway.
    Zhang H; Gong X; Ni S; Wang Y; Zhu L; Ji N
    Int Immunopharmacol; 2019 Dec; 77():105934. PubMed ID: 31727560
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-30c-5p inhibits NLRP3 inflammasome-mediated endothelial cell pyroptosis through FOXO3 down-regulation in atherosclerosis.
    Li P; Zhong X; Li J; Liu H; Ma X; He R; Zhao Y
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2833-2840. PubMed ID: 30119891
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-155 activates the NLRP3 inflammasome by regulating the MEK/ERK/NF-κB pathway in carotid atherosclerotic plaques in ApoE
    Peng Q; Yin R; Zhu X; Jin L; Wang J; Pan X; Ma A
    J Physiol Biochem; 2022 May; 78(2):365-375. PubMed ID: 35079982
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0007478 aggravates NLRP3 inflammasome activation and lipid metabolism imbalance in ox-LDL-stimulated macrophage via miR-765/EFNA3 axis.
    Ye B; Liang X; Zhao Y; Cai X; Wang Z; Lin S; Wang W; Shan P; Huang W; Huang Z
    Chem Biol Interact; 2022 Dec; 368():110195. PubMed ID: 36191606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin Ameliorates the Progression of Atherosclerosis via Mitophagy Activation and NLRP3 Inflammasome Inhibition.
    Ma S; Chen J; Feng J; Zhang R; Fan M; Han D; Li X; Li C; Ren J; Wang Y; Cao F
    Oxid Med Cell Longev; 2018; 2018():9286458. PubMed ID: 30254716
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rutaecarpine derivative R3 attenuates atherosclerosis via inhibiting NLRP3 inflammasome-related inflammation and modulating cholesterol transport.
    Luo J; Wang X; Jiang X; Liu C; Li Y; Han X; Zuo X; Li Y; Li N; Xu Y; Si S
    FASEB J; 2020 Jan; 34(1):1398-1411. PubMed ID: 31914630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MLKL Aggravates Ox-LDL-Induced Cell Pyroptosis via Activation of NLRP3 Inflammasome in Human Umbilical Vein Endothelial Cells.
    Wu Q; He X; Wu LM; Zhang RY; Li LM; Wu CM; Lu YB; Hu B; Shi C; Lu ZF; Yang B; Zheng L; Hu YW; Wang Q
    Inflammation; 2020 Dec; 43(6):2222-2231. PubMed ID: 32621119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fucoidan Inhibits NLRP3 Inflammasome Activation by Enhancing p62/SQSTM1-Dependent Selective Autophagy to Alleviate Atherosclerosis.
    Cheng Y; Pan X; Wang J; Li X; Yang S; Yin R; Ma A; Zhu X
    Oxid Med Cell Longev; 2020; 2020():3186306. PubMed ID: 33505579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel Role for Tranilast in Regulating NLRP3 Ubiquitination, Vascular Inflammation, and Atherosclerosis.
    Chen S; Wang Y; Pan Y; Liu Y; Zheng S; Ding K; Mu K; Yuan Y; Li Z; Song H; Jin Y; Fu J
    J Am Heart Assoc; 2020 Jun; 9(12):e015513. PubMed ID: 32476536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exposure of cigarette smoke condensate activates NLRP3 inflammasome in THP-1 cells in a stage-specific manner: An underlying role of innate immunity in atherosclerosis.
    Mehta S; Dhawan V
    Cell Signal; 2020 Aug; 72():109645. PubMed ID: 32305666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldehyde dehydrogenase 2 inhibited oxidized LDL-induced NLRP3 inflammasome priming and activation via attenuating oxidative stress.
    Xu Y; Yuan Q; Cao S; Cui S; Xue L; Song X; Li Z; Xu R; Yuan Q; Li R
    Biochem Biophys Res Commun; 2020 Sep; 529(4):998-1004. PubMed ID: 32819611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Air pollution is associated with the development of atherosclerosis via the cooperation of CD36 and NLRP3 inflammasome in ApoE
    Du X; Jiang S; Zeng X; Zhang J; Pan K; Zhou J; Xie Y; Kan H; Song W; Sun Q; Zhao J
    Toxicol Lett; 2018 Jun; 290():123-132. PubMed ID: 29571893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. K63 ubiquitin chains target NLRP3 inflammasome for autophagic degradation in ox-LDL-stimulated THP-1 macrophages.
    Zhou Z; Zhu X; Yin R; Liu T; Yang S; Zhou L; Pan X; Ma A
    Aging (Albany NY); 2020 Jan; 12(2):1747-1759. PubMed ID: 32003754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Astragaloside IV protects endothelial progenitor cells from the damage of ox-LDL via the LOX-1/NLRP3 inflammasome pathway.
    Qian W; Cai X; Qian Q; Zhuang Q; Yang W; Zhang X; Zhao L
    Drug Des Devel Ther; 2019; 13():2579-2589. PubMed ID: 31440038
    [No Abstract]   [Full Text] [Related]  

  • 20. Cholesterol Efflux Pathways Suppress Inflammasome Activation, NETosis, and Atherogenesis.
    Westerterp M; Fotakis P; Ouimet M; Bochem AE; Zhang H; Molusky MM; Wang W; Abramowicz S; la Bastide-van Gemert S; Wang N; Welch CL; Reilly MP; Stroes ES; Moore KJ; Tall AR
    Circulation; 2018 Aug; 138(9):898-912. PubMed ID: 29588315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.